Annual EBITDA
-$81.00 M
-$57.77 M-248.67%
December 31, 2023
Summary
- As of March 12, 2025, NKGN annual EBITDA is -$81.00 million, with the most recent change of -$57.77 million (-248.67%) on December 31, 2023.
- During the last 3 years, NKGN annual EBITDA has fallen by -$60.30 million (-291.28%).
- NKGN annual EBITDA is now -291.28% below its all-time high of -$20.70 million, reached on December 31, 2021.
Performance
NKGN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$7.40 M
+$22.52 M+148.97%
September 1, 2024
Summary
- As of March 12, 2025, NKGN quarterly EBITDA is $7.40 million, with the most recent change of +$22.52 million (+148.97%) on September 1, 2024.
- Over the past year, NKGN quarterly EBITDA has stayed the same.
- NKGN quarterly EBITDA is now at all-time high.
Performance
NKGN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$44.56 M
+$40.07 M+47.35%
September 1, 2024
Summary
- As of March 12, 2025, NKGN TTM EBITDA is -$44.56 million, with the most recent change of +$40.07 million (+47.35%) on September 1, 2024.
- Over the past year, NKGN TTM EBITDA has stayed the same.
- NKGN TTM EBITDA is now -635.69% below its all-time high of -$6.06 million, reached on September 1, 2022.
Performance
NKGN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NKGN EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -248.7% | 0.0% | 0.0% |
3 y3 years | -291.3% | +222.2% | -635.7% |
5 y5 years | -291.3% | +222.2% | -635.7% |
NKGN EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -291.3% | at low | at high | +122.5% | -635.7% | +47.4% |
5 y | 5-year | -291.3% | at low | at high | +122.5% | -635.7% | +47.4% |
alltime | all time | -291.3% | at low | at high | +122.5% | -635.7% | +47.4% |
NKGen Biotech EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $7.40 M(-149.0%) | -$44.56 M(-47.3%) |
Jun 2024 | - | -$15.12 M(+279.1%) | -$84.63 M(+9.9%) |
Mar 2024 | - | -$3.99 M(-87.9%) | -$77.00 M(-4.9%) |
Dec 2023 | -$81.00 M | -$32.86 M(+0.6%) | -$81.00 M(+49.6%) |
Sep 2023 | - | -$32.67 M(+336.2%) | -$54.16 M(+96.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2023 | - | -$7.49 M(-6.2%) | -$27.55 M(+37.3%) |
Mar 2023 | - | -$7.98 M(+32.6%) | -$20.06 M(+66.1%) |
Dec 2022 | -$23.23 M(+12.2%) | -$6.02 M(-0.6%) | -$12.08 M(+99.4%) |
Sep 2022 | - | -$6.06 M | -$6.06 M |
Dec 2021 | -$20.70 M | - | - |
FAQ
- What is NKGen Biotech annual EBITDA?
- What is the all time high annual EBITDA for NKGen Biotech?
- What is NKGen Biotech annual EBITDA year-on-year change?
- What is NKGen Biotech quarterly EBITDA?
- What is the all time high quarterly EBITDA for NKGen Biotech?
- What is NKGen Biotech quarterly EBITDA year-on-year change?
- What is NKGen Biotech TTM EBITDA?
- What is the all time high TTM EBITDA for NKGen Biotech?
- What is NKGen Biotech TTM EBITDA year-on-year change?
What is NKGen Biotech annual EBITDA?
The current annual EBITDA of NKGN is -$81.00 M
What is the all time high annual EBITDA for NKGen Biotech?
NKGen Biotech all-time high annual EBITDA is -$20.70 M
What is NKGen Biotech annual EBITDA year-on-year change?
Over the past year, NKGN annual EBITDA has changed by -$57.77 M (-248.67%)
What is NKGen Biotech quarterly EBITDA?
The current quarterly EBITDA of NKGN is $7.40 M
What is the all time high quarterly EBITDA for NKGen Biotech?
NKGen Biotech all-time high quarterly EBITDA is $7.40 M
What is NKGen Biotech quarterly EBITDA year-on-year change?
Over the past year, NKGN quarterly EBITDA has changed by $0.00 (0.00%)
What is NKGen Biotech TTM EBITDA?
The current TTM EBITDA of NKGN is -$44.56 M
What is the all time high TTM EBITDA for NKGen Biotech?
NKGen Biotech all-time high TTM EBITDA is -$6.06 M
What is NKGen Biotech TTM EBITDA year-on-year change?
Over the past year, NKGN TTM EBITDA has changed by $0.00 (0.00%)